Guerbet Group (PAR: GBT)

Guerbet Group is a corporation based in Villepinte, France. Established in 1926, the firm is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for X-ray imaging, magnetic resonance imaging, ultrasound imaging, and nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol. The assets are managed by its executive team.